Sam Possemiers

Company: MRM Health

Job title: Chief Executive Officer

Seminars:

MH002, a 6-strain Optimized Consortium in Clinical Development for Ulcerative Colitis & Pouchitis 12:00 pm

Discover how MH002 was developed through MRM Health’s proprietary CORAL® platform, allowing manufacturing of complete consortia in a single process Reviewing MH002’s multifactorial mechanism-ofaction includes gut barrier restoration, mucosal healing and immunomodulation Sharing a status update of both ongoing clinical trialsRead more

day: Conference Day Two Track B AM 1